Skip to main content

EVEROLIMUS

NDC 72603-254 · NorthStar RxLLC

Generic nameeverolimus
Dosage formTABLET
RouteORAL
Active ingredient(s)EVEROLIMUS
Strength2.5 mg/1
Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryANDA

Packages

72603-254-01 — 30 TABLET in 1 BOTTLE (72603-254-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70377-011 — everolimus, 70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-090 — Everolimus, 70377-091 — Everolimus, 70377-092 — Everolimus, 70377-112 — everolimus, 72603-255 — everolimus, 72603-256 — everolimus, 72603-257 — everolimus, 82249-610 — Everolimus, 82249-611 — Everolimus, 82249-612 — Everolimus, 82249-613 — Everolimus, 82293-030 — everolimus, 82293-031 — everolimus, 82293-032 — everolimus, +63 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.